The Latest Breaking News from ELV

Elevance Health is scheduled to report its first-quarter results this month, and analysts expect a single-digit earnings growth.

Due to Cigna Group’s outperformance relative to its healthcare sector on a YTD basis, Wall Street analysts maintain bullish about the stock’s prospects.

The S&P 500 is a treasure trove for investors seeking undervalued stocks offering significant gains. Given this backdrop, it might be wise to scoop up shares of undervalued S&P 500 stocks, Comcast Corp (CMCSA), Elevance Health (ELV), and HCA Healthcare (HCA), offering a chance to capitalize on potential upside. Keep…

While Elevance Health has lagged behind the broader market substantially over the past year, Wall Street analysts remain highly optimistic about the stock's future potential.

Elevance Health stock is plunging Thursday after the insurer missed Q3 earnings expectations and lowered its full-year outlook. Here's what you need to know.

Elevance Health is expected to release its third-quarter earnings later this month and analysts expect a high-single-digit earnings growth.

During economic uncertainty, dividend growth stocks are a smart choice for stable passive income, inflation protection, and potential for increasing dividends, offering security in a volatile market. Therefore, investors might consider buying dividend growth stocks like Elevance Health (ELV), Enterprise Products Partners (EPD), and HP (HPQ), each with over 10…

With rising medical costs and an expanding aging population, the health insurance sector is set to witness significant growth. Hence, investors looking to capitalize on this trend could consider stable health insurance stocks Elevance Health (ELV), Cigna Group (CI), and Centene (CNC). Read on….

Elevance Health has outperformed the Nasdaq Composite over the past year, and Wall Street analysts remain optimistic about the stock’s prospects.